Endo's Ch11 recognised, stalling claims in UK and Australia

UK and Australian courts have recognised the Chapter 11 proceedings of a US affiliate of Irish-registered pharma group Endo, staying multiple claims brought against it in those jurisdictions by women who say they suffered as a result of its pelvic mesh products.

Unlock unlimited access to all Global Restructuring Review content